Healthtech Startups
16,794 companies tagged Healthtech, with their investors and founders.
Gifthealth operates a digital platform that connects pharmaceutical manufacturers, prescribers, and patients to streamline prescription fulfillment and medication access nationwide. The company addresses barriers in specialty pharmacy care through an integrated hub model that handles prescription intake, fulfillment, and patient adherence.
3 investors
Gigasheet transforms large healthcare price transparency datasets into market intelligence and benchmarking tools for providers, payers, and self-insured benefits partners. The platform uses AI to analyze billions of healthcare rates and contracts, enabling users to benchmark pricing, identify reimbursement trends, and optimize contract negotiations.
3 investors
Neptune Medical designs and manufactures medical devices using proprietary Dynamic Rigidization technology that toggles thin-walled tubes between flexible and rigid states. Its flagship product, Pathfinder, is an FDA-cleared overtube for endoscopy procedures used in diagnostic and therapeutic GI endoscopy at U.S. hospitals and medical centers.
3 investors
Givers enrolls, supports, and pays family caregivers through U.S. state programs, helping them determine eligibility, get enrolled, and receive ongoing payment, coaching, and training. The service targets individuals caring for a parent, spouse, or child, using an app to document daily care and manage the process.
3 investors
Gladys operates an online platform that connects families directly with local carers and helpers for at-home elderly and social care, cutting out agency overheads to lower costs for families and increase carer pay. The company serves families in the UK arranging home care for older or vulnerable loved ones.
3 investors
Glass Health provides an AI platform that assists clinicians in generating diagnostic hypotheses and developing treatment plans.
3 investors
GHX operates a cloud-based supply chain network connecting healthcare providers, suppliers, and distributors to optimize procurement and clinical outcomes. The platform helps healthcare organizations achieve supply chain resilience, ERP transformation, and value-based purchasing decisions.
3 investors
Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
3 investors
GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota. It works with clients on collaborative R&D, clinical validation, and IP licensing of its patented technologies, with research based at the Texas Medical Center in Houston.
3 investors
GoCheck Kids offers a smartphone-based MultiScreener that combines photoscreening, visual acuity, and pure tone audiometry to screen young children for vision and hearing problems. Its technology is used by pediatric healthcare providers to detect risk factors for amblyopia and hearing loss early.
3 investors
A pharmaceutical company that markets a portfolio of drug products across various dosage forms, with labeling and packaging following FDA requirements. Its products and prescribing information are registered under labeler codes 60429 and 51407 and listed on DailyMed.
3 investors
GondolaBio is a clinical-stage biopharmaceutical company developing therapeutics for patients with genetic diseases, with a lead oral small-molecule program (PORT-77) targeting erythropoietic protoporphyria and X-linked protoporphyria. A sister company of BridgeBio Pharma launched in 2024, it runs a decentralized drug-development model with a pipeline spanning multiple rare genetic conditions.
3 investors
Goodair makes Nosebuds, a reusable, drug-free nasal device worn inside the nostrils that uses small rotors to generate a vibroacoustic hum, stimulating nasal cilia to clear mucus and allergens and relieve congestion. It is marketed as a consumer wellness product for people with blocked nose, sinusitis, rhinitis, allergies, and colds, sold across New Zealand and Australia.
3 investors
Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment. The company applies chemistry to medical and healthcare applications for patients and clinicians.
3 investors
Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases. The company operates manufacturing facilities in China and was acquired by AstraZeneca in February 2024.
3 investors
Gradia provides a virtual care platform for patients with chronic conditions, offering integrated communication and specialized care coordination between clinic appointments to supplement traditional in-person care.
3 investors
Gradient AI develops underwriting and claims management software for group health, property & casualty, and workers' compensation insurance. The platform serves carriers, brokers, MGAs, TPAs, and PEOs.
3 investors
Grapefruit Health provides healthcare organizations with a workforce of trained clinical students—recruited from pre-med, nursing, pharmacy, social work, and similar programs—who are integrated into care team workflows to close care gaps and address staffing shortages. It handles recruiting, vetting, training, and quality assurance for these students, who serve as "Patient Champions" for healthcare provider clients in the US.
3 investors
GraphiteRx operates a marketplace platform that connects pharmacies, hospitals, clinics, and suppliers to streamline healthcare distribution. The company focuses on improving access to healthcare products while reducing costs and complexity in the healthcare supply chain.
3 investors
Grit Bio develops nine core technology platforms for cell therapy manufacturing and development, spanning TIL expansion, viral vector production, immunological target discovery, and LNP delivery systems for therapeutic applications.
3 investors
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function. Its pipeline is built on two NSAA chemistry families—DuraLogic for therapeutic stability and dosing, and ProGly for biologics addressing autoimmune disease and immunogenicity.
3 investors
Grove AI builds "Grace," an AI agent and participant relationship management (PRM) platform that automates clinical trial recruitment tasks such as prescreening, participant inquiries, and appointment scheduling. It serves clinical research sites, CROs, and pharmaceutical sponsors in the life sciences industry.
3 investors
Grüns makes nutrient-dense gummy supplements formulated with 60+ whole-food ingredients designed to provide comprehensive daily nutrition. The company targets consumers seeking convenient, portable nutrition alternatives to pills and powders.
3 investors
ComplianceAssist is an AI-powered auditing platform for long-term care facilities that monitors electronic health records across 28 clinical domains to identify documentation gaps and compliance risks. The system automatically surfaces issues and routes them to nursing staff with actionable corrections, enabling facilities to resolve compliance deficiencies before regulatory surveys.
3 investors